Saquinavir in the management of HIV infection.
Renewed optimism for the treatment of HIV infection has arisen with the advent of potent antiretroviral cocktails which, for many patients, provide sustained control of viral replication, and enable at least partial immune regeneration and improved quality of life. Proteinase inhibitor drugs, such as saquinavir, represent the key agents for attaining the new therapy goals.
Moyle
G
G
Kobler Clinic, Chelsea and Westminster Hospital, London.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019258:Saquinavir / Q000627:therapeutic use*; D014779:Virus Replication / Q000187:drug effects
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019258:Saquinavir